[1]
D. Mirowska-Guzel, “Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review”, Prospect. Pharm. Sci., vol. 24, no. 2, pp. 149–160, Jun. 2026.